Michael J. Detke - Chief Medical Officer at Quince Therapeutics, Inc.

Issuer-level insider activity

Role
Chief Medical Officer
Issuer ticker
QNCX on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Michael J. Detke since 06 Oct 2025

Reported holdings for Michael J. Detke in Quince Therapeutics, Inc.

Form 4 holding Chief Medical Officer

Cortexyme, Inc.

Security class
Common Stock
Shares / value
140,000
Estimated value
$131,600
Report date
03 Mar 2022
Price
$0.9400
Ownership
Direct

Transaction history for Michael J. Detke in Quince Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .